Adam Bagg
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Attending in Hematopathology, Laboratory Hematology, Flow Cytometry and Molecular Pathology, Hospital of the University of Pennsylvania
Director, Hematology, Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine
Contact information
Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
7.103 Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104-4283
Hospital of the University of Pennsylvania
7.103 Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-4280
Fax: 215-662-7529
Fax: 215-662-7529
Email:
adambagg@mail.med.upenn.edu
adambagg@mail.med.upenn.edu
Education:
MB. BCh (magna cum laude)
University of the Witwatersrand, South Africa, Top 1% of graduating class, 1981.
Permanent linkMB. BCh (magna cum laude)
University of the Witwatersrand, South Africa, Top 1% of graduating class, 1981.
Description of Research Expertise
Molecular genetics and pathology of Leukemias and Lymphomas; Myelodysplastic syndromes; Minimal residual disease; Hodgkin lymphomaDescription of Itmat Expertise
Dr. Bagg studies: (1) the diagnostic molecular pathology of hematologic malignancies, with the development of novel assays to facilitate their diagnosis; (2) minimal residual disease testing in leukemia, lymphoma and myeloma; and (3) unraveling the biology and improving the laboratory diagnosis of the myelodysplastic syndromes.Selected Publications
Nybakken G and Bagg A: Myelodysplastic Syndromes. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. Jianguo Tao and Eduardo Sotomayor (eds.). Springer, 2012 (in press).Raess P, Bagg A: The Role of Molecular Pathology in the Diagnosis of Cutaneous Lymphomas. Pathology Research International 2012 (in press).
Wertheim G, Hexner EO, Bagg A. : Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations. Molecular Diagnosis & Therapy Nov 2012
Wertheim G, Daber R, Bagg A.: Molecular Diagnostics of Acute Myeloid Leukemia: It's a (Next) Generational Thing. Journal of Molecular Diagnostics Page: S1525-1578, Nov 2012
Roy D, and Bagg A: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Pathology Case Reviews 17: 84-89, 2012.
Ochs R, and Bagg A: Molecular Genetic Characterization of Lymphoma: Application of Cytology Diagnosis. Diagnostic Cytopatholgy 40: 542-55, 2012.
Raess PW, Paessler ME, Bagg A, Weiss MJ, Choi JK.: Alpha-hemoglobin stabilizing protein is a sensitive and specific marker of erythroid precursors. American Journal of Surgical Pathology 36: 1538-47, 2012.
Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song J, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset R, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E.: In-situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 2012.
Gan Y, Shinohara M, Rosenbach M, Elder D, Frey N, Bagg A.: A Transient blood transfusion reaction masquerading as a post-transplant lymphoproliferative disorder mimicking acute leukemia cutis. Journal of Clinical Oncology 29(29), Oct 2011
Bagg, A.: Therapy-associated lymphoid proliferations. Advances in Anatomic Pathology 18: 199-205, 2011